EBS
Emergent BioSolutionsCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
EBS vs peer average
55/100
EBS vs. peer average (C vs. C)
Grade spread
B 4 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
KMDA is the first available peer comparator.
Kamada is the closest name in the provided peer set because it has specialty biologics and critical-care exposure, but it remains an imperfect comparator for EBS's biodefense, medical-countermeasure, contract-manufacturing, and naloxone mix.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EBS
Emergent BioSolutions
KMDA
Kamada
Grade
C
B
Momentum
11
28
Value
72
65
Sentiment
67
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs KMDA
EBS / KMDA
Grade Position
In line
EBS vs. peer average (C vs. C)
55/100
Momentum
11
KMDAValue
72
EBSSentiment
67
KMDARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EBS
KMDA is the first peer returned for this comparison set.